Molecular Pathways Leading to Cancer Cachexia
- 1 October 2005
- journal article
- review article
- Published by American Physiological Society in Physiology
- Vol. 20 (5), 340-348
- https://doi.org/10.1152/physiol.00019.2005
Abstract
Loss of body weight in cancer patients strongly influences morbidity and mortality. Recent studies have suggested that both tumor and host factors play a major role in tissue catabolism in cachexia, leading to upregulation of degradative pathways in both skeletal muscle and adipose tissue.Keywords
This publication has 62 references indexed in Scilit:
- Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight lossThe International Journal of Biochemistry & Cell Biology, 2005
- Hyperlipemia: a role in regulating UCP3 gene expression in skeletal muscle during cancer cachexia?FEBS Letters, 2001
- Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factorBritish Journal of Surgery, 2000
- In the rat, tumor necrosis factor α administration results in an increase in both UCP2 and UCP3 mRNAs in skeletal muscle: a possible mechanism for cytokine‐induced thermogenesis?FEBS Letters, 1998
- Longitudinal study of body cell mass depletion and the inflammatory response in cancer patientsNutrition and Cancer, 1998
- Structural Analysis of a Tumor-produced Sulfated Glycoprotein Capable of Initiating Muscle Protein DegradationPublished by Elsevier BV ,1997
- Serum levels of tumour necrosis factor alpha and other cytokines do not correlate with weight loss and anorexia in cancer patientsSupportive Care in Cancer, 1997
- Anti-interferon-γ antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexiaEuropean Journal of Cancer and Clinical Oncology, 1991
- Protein synthesis in muscle measured in vivo in cachectic patients with cancer.BMJ, 1984
- Skeletal muscle metabolism in patients with malignant tumorEuropean Journal of Cancer (1965), 1976